alopecia
ALOPECIA

Alopecia is an involuntary loss of hair usually in the scalp that may occur anywhere over the body.
Scarring alopecia is severe inflammation of the hair follicle result in irreversible damage.
Non-scarring alopecias are reversible.
Alopecia may  be abrupt or gradual in onset.
Most common causes include androgenic alopecia (male & female pattern baldness) & alopecia areata.
History should be reviewed for medications, severe diet restriction, vitamin A supplementation, thyroid symptoms, concomitant illness & stress factor.

Surgical Intervention

Hair Transplantation
  • Surgical option for androgenic alopecia and androgenic alopecia where hairs from the back and sides of the scalp are transplanted to balding areas in the front
    • Usually need 2-4 sessions depending on the number of grafts transplanted per session
    • Success depends on the viability of grafts harvested and inserted into areas with hair loss
    • Mini-grafts and micro-grafts with 2-4 follicles allows for a more natural looking result
  • Follicular unit transplantation (FUT) may be considered for both men and women with alopecia areata with sufficient donor hair
  • Has limited aesthetic benefit for MPHL with Norwood/Hamilton stages I-II
  • Not optimal surgical candidate for FPHL with Ludwig I stage; best candidate are patients with Ludwig stage II
Scalp Reduction (Alopecia Reduction Surgery)
  • Treatment option for male patients with hair loss at the back of the scalp
  • Area with hair loss is surgically removed and hair-bearing scalp is stretched to fill in the void left by the excised scalp
  • May be performed with hair transplantation or scalp expansion
  • Has limited aesthetic benefit for MPHL with Norwood/Hamilton stages I-III because of potential for scarring
Editor's Recommendations
Most Read Articles
Pearl Toh, 15 May 2018
Biologic therapy for treating psoriasis, in particular anti-TNF agents, can also help reduce coronary plaque besides suppressing inflammation in the skin, suggests a study presented at the Society for Cardiovascular Angiography and Interventions (SCAI) 2018 Scientific Sessions in San Diego, California, US.
Tristan Manalac, 10 Mar 2018
Cost of treatment is a major driver of patients’ primary nonadherence to acne medication, according to a recent study. Physicians who openly discuss medications costs and provide a plan of action in case patients are unable to fill prescriptions may improve treatment adherence.
01 Aug 2015
A higher dose of amikacin enhanced the rates of pharamacodynamic target attainment in simulations of paediatric patients with burn wound sepsis, based on a study.
31 Jan 2018
Oral tranexamic acid (TA) may help improve moderate-to-severe melasma with negligible side effects, according to a recent study.